Market Overview

AMAG Pharma Names Greg Madison Chief Commercial Officer

Related AMAG
Benzinga's M&A Chatter for Monday June 29, 2015
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Operating Margin
AMAG Pharma (Investor's Business Daily)

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Greg Madison as executive vice president and chief commercial officer. Mr. Madison brings a wealth of hands-on commercial experience and extensive leadership skills to AMAG. He joins AMAG from Genzyme Corporation, where he spent the past 12 years in various commercial roles in their renal division, most recently as the division's vice president and general manager.

Posted-In: News Management


Related Articles (AMAG)

Around the Web, We're Loving...

Get Benzinga's Newsletters